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ABSTRACT 
Objective: Alysicarpus monilifer (Family Papilionaceae) has been used in the Indigenous system of medicine in tumor removal. The present study 
was designed to isolate and identify the constituent responsible for cytotoxic (anti-tumor) effects of the plant Alysicarpus monilifer.  
Methods: The plant was powdered and extracted to give a methanolic extract. Initially, Hexane, chloroform, ethyl acetate and methanolic fractions 
of the methanolic extract of the plant were subjected to cytotoxic screening using cell line based assay (MTT assay and NRU assay). The chloroform 
fraction showed significant cytotoxicity, so it was further subjected to column chromatography, to separate the cytotoxic phytoconstituent. The cell 
lines selected were breast cancer cells (MCF-7 and MDA-MB-468) and Liver cancer cells (HepG2 and HLE cell). Results were calculated as 
percentage growth inhibition with respect to untreated (control) cells versus treated cells.  
Result: A triterpene, Betulinic acid, was isolated from the aerial parts of Alysicarpus monilifer. The cytotoxic activity of the identified compound 
against MCF-7, MDA-MB-231, HLE and HepG2 cells was also found to be highly significant with 90% growth inhibition.  
Conclusion: The triterpene was identified to be betulinic acid, to which the cytotoxic activity can be attributed. It is a first report of isolation of 
betulinic acid from the Alysicarpus species. 
Keywords: Alysicarpus monilifer, Betulinic acid, Pentacyclic triterpenoid, Phytochemistry, In vitro cytotoxicity, Phytopharmacology 




Alysicarpus monilifer L.(DC.) (Papilionaceae), commonly known as 
Juhi ghas (Hindi) or Samervo (Gujarati), is a turf forming legume [1, 
2]. In India it is found to be distributed throughout the plains-
Bombay, Madras, Jammu, Punjab, Gujarat (except Kutch and Bulsar), 
Uttar Pradesh and Madhya Pradesh [3].  
The plant has been used in indigenous system of medicine as an 
antidote to snake bite [4, 5], anti-inflammatory and in stomach-ache 
1
MATERIALS AND METHODS 
. The leaves are used in jaundice and in fever [6, 7]. It is also used as 
a diuretic, in tumor removal and in skin diseases [8-11].  
The plant was found to contain C-glycosyl flavones such as vitexin 
and isovitexin triterpene named as Alysinol (3-alpha, 22beta-
dihydroxyolean-12-ene) along with known compounds like usnic 
acid, methyl 2,4-dihydroxy-3,6-dimethyl benzoate, 3-hydroxy 
benzoic acid, stigmasterol, poriferasterol and ursolic acid, 
carbohydrates, fixed oils, phenolics and tannins from the studies 
[12-15]. Methanolic extracts of aerial parts of A. monilifer 
demonstrated promising analgesic and anti-inflammatory activity 
[16, 17]. The methanolic extract was also shown to protect liver 
function and reduce oxidative stress [12]. Karthikeyan (2017) 
demonstrated the prominent anti-diabetic activity of A. monilifer 
streptozotocin-induced diabetic rats [18]. 
The aerial parts of A. monilifer are indicated as anti-tumor agents in 
ethnobotany, but this has not been proved pharmacologically. So it 
was thought worthwhile to carry out investigations for the same. It 
was further proposed to isolate phytoconstituents responsible for 
cytotoxic activity from the fractions of methanolic extracts of aerial 
parts of the plant by adopting bioactivity guided fractionation 
approach. These phytoconstituents were planned to be 
characterized chemically using spectral methods.  
Authentication of plant material 
The fully grown plants of A. monilifer L.(DC.) was collected from New 
Vallabh Vidyanagar region of Anand. It was collected from July to 
October, when flowering and fruiting season is observed. The 
authentication was carried out by Dr. Suman Chandra Sharma, 
Taxonomist, Department of Botany, Government Dungar College, 
Bikaner, Rajasthan. The voucher specimen was deposited with 
Department of Pharmacognosy, Ramanbhai Patel College of 
pharmacy, Changa (CHARUSAT) with voucher specimen number 
2012/PK/AM. 
Preparation and collection of plant material 
Dried aerial parts of A. monilifer were used for phytochemical 
studies. The aerial plant parts were dried under shade and 
powdered coarsely, stored in airtight containers and used for 
further studies. 
Extraction 
The shade dried, powdered aerial parts of A. monilifer (20 kg) 
were soaked in methanol and the extraction process repeated 
thrice. The methanolic extract (AM-1) obtained was evaporated 
under reduced pressure to obtain greenish gummy material 
(950g), which was then dissolved in water and extracted with n-
hexane to yield hexane fraction (AM-2). The water layer further 
partitioned with chloroform to yield a chloroform fraction (AM-2). 
The aqueous layer was partitioned with ethyl acetate to yield ethyl 
acetate fraction (AM-3). The leftover aqueous layer was 
evaporated to give a residue, which was dissolved in methanol to 
yield a methanolic fraction (AM-4) [19, 20]. The extraction can be 
schematically represented as in fig. 1 
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Fig. 1: Fractionation scheme of AM-1 of A. monilifer 
 
Bioactivity-guided fractionation 
In a biological activity-guided fractionation approach, the 
methanolic (AM-1) extract was investigated for cytotoxic activity 
against four cancer cell lines. A series of eight dilutions of AM-1 (10-
500 µg/ml) was used to determine the concentration-dependent 
cytotoxic effect on four cancer cell lines (MCF-7, MDA-MB-231, 
HepG2 and HLE cell lines) after 24 hr treatment, using two 
cytotoxicity assays; MTT and neutral red uptake (NRU) assays. 
The direct methanolic extract (AM-1) of the plant was partitioned 
into Hexane (AM-2), Chloroform (AM-3), ethyl acetate (AM-4) and 
methanolic (AM-5) fractions (fig. 1). These fractions were tested, 
individually, for cytotoxic activity on all four cancer cell lines (MCF-
7, MDA-MB-231, HepG2 and HLE cell lines). For each fraction, a final 
concentration of 200 µg per well was prepared in the medium 
containing DMSO (Dimethyl sulfoxide, maximum: 0.01 %) and tested 
using MTT and NRU assays using the same protocol conditions as in 
the case of AM-1. 
Purification of AM-3 
AM-3 was biologically more active than the other fractions. So 
purification of AM-3 was carried out using column chromatography. 
Purification of AM-3 in column chromatography with silica gel 
employed an isocratic elution system of ethyl acetate: hexane: 
acetone (7:3:5) as eluting solvent. This resulted in the isolation of a 
triterpenoid compound AMB 004.  
Assessment of purity of AMB 004 
The purity of the AMB 004 was checked by performing HPLC and 
TLC. The compound had a characteristic peak under optimized 
chromatographic conditions in HPLC, with 98.2% purity calculated 
by area normalization. While in TLC, a single spot was obtained in 
the mobile phase. 
Cytotoxicity assays 
Cellular damage will inevitably result in a loss of the ability of the 
cell to maintain and provide energy for metabolic cell function and 
growth. A number of methods have been developed to study cell 
viability and proliferation in cell populations. One parameter used as 
the basis for colorimetric assays is the metabolic activity of viable 
cells. Both qualitative and quantitative cell viability assays have been 
developed in a microplate format (96-well plates). 
Human cell lines collection 
The cell lines MCF-7, MDA MB-231, HepG2 and HLE cell lines were 
selected for the studies. MCF-7 is a human breast estrogen-dependent 
cancer cells. MCF-7 is short form from of Michigan Cancer Foundation-7 
(An institute in Detroit) where the cell line was originally established by 
Herbert Soule and co-workers in the year 1973. MDA-MB-231 stands for 
M. D. Anderson-metastatic breast-231. It is human breast cancer cells, 
which lacks oestrogen receptors i.e. it is estrogen-independent 
adenocarcinoma. HepG2 is a human liver cancer cell line; while HLE cell 
line is undifferentiated human Hepatoma cells.  
Procurement and culturing of cell lines 
The cell lines, MCF-7, MDA MB-231, HepG2 and HLE cell lines were 
procured from the National Centre for Cell Science, Pune, India. The 
cell lines were grown in an incubator at 37 °C in an atmosphere that 
contains 5% CO2 and 90 % Relative humidity. The cells were 
maintained in the form of monolayer in Eagle’s minimum essential 
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media (EMEM) (procured from Sigma Aldrich), supplemented with 
10 % fetal calf serum, 20 mmol l-glutamine, 2% penicillin-
streptomycin, and 0.2 % gentamicin in a carbon dioxide incubator 
(37 °C, 5% CO2, 90% Relative Humidity). Cells were passaged 
routinely. The cells after sub-passage were harvested from the flask 
by treatment with trypsin (0.05% in PBS (pH 7.4) containing 0.02% 
EDTA). Cells with viability of more than 98% (as determined by 
trypan blue exclusion) were used for determination of cytotoxicity. 
Cytotoxicity of fractions and compound was assessed using MTT 
assay and Neutral Red uptake (NRU) assay. The methodologies 
adopted are described in brief. [22, 23]  
Preparation of test solution 
A series of eight dilutions, i.e. 10, 25, 50, 100, 200, 300, 400 and 500 
µg/ml concentrations of AM-1 were prepared in the medium 
containing DMSO. Cells were seeded into 96-well cell culture plates 
at a density of 1 x104 cells per well in 100 µl aliquots of the medium. 
The cells were allowed to attach for 24 hr in a carbon dioxide 
incubator (37 °C, 5 % CO2
Where: Control = absorbance of untreated cells after subtracting 
absorbance of media 
Actual absorbance = absorbance of treated cells at a particular 
concentration of testing sample after subtracting the absorbance of 
media 
Neutral red uptake (NRU) assay 
In each well of a 96-well cell culture plate, serial dilutions of each 
sample, understudy and standard were added in the cell culture 
medium containing cancer cell lines. An aliquot of 1 × 10
, 90 % RH). After a 24 hr exposure period, 
the % inhibitions were determined using two colorimetric assays; 
namely the MTT assay and NRU assay. 
As the plant showed moderate to good cytotoxic activity, the next 
step was to find out the cytotoxic fraction from the above extracts. 
Hexane (AM-2), Chloroform (AM-3), Ethyl acetate (AM-4) and 
Methanol (AM-5) fractions from direct methanolic extract (AM-1) of 
A. monilifer were tested, individually, for cytotoxic activity on four 
cancer cell lines (MCF-7, MDA-MB-231, HepG2 and HLE cell lines). 
For each fraction, a final concentration of 200 µg per well was 
prepared in the medium containing DMSO (Dimethyl sulfoxide, 
maximum: 0.01 %) and tested using MTT and NRU assays using the 
same protocol conditions as in the case of AM-1. AM-3 was found to 
possess the most significant cytotoxic activity. AM-3, on purification 
using column chromatography, gave a triterpenoidal compound. 
This compound was identified as Betulinic acid with the help of 
spectral studies. 
Cytotoxic activity of compound Betulinic acid from A. monilifer was 
evaluated at 24 hr and 48 hr in order to establish a time-dependent 
as well as concentration-dependent cytotoxic effect. Actinomycin-D 
(4 µM), Tamoxifen (5 µM) and Anastrozole (5 µM) were used as 
standards. A serial dilution of eight concentrations (0.78, 1.56, 3.12, 
6.25, 12.5, 25, 50, 100 µM) for isolated compound Betulinic acid was 
tested using MTT and NRU assays, for 24 hr and 48 hr treatments.  
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] assay (MTT assay) 
According to the method described by Borenfreund et al., [22] 
growth of cancer cells was quantified. The cells, grown in a 96 well 
tissue culture plate, were exposed to the drug in question and 
incubated for about 24 hr. Following the incubation period, cells 
were washed twice with PBS (Phosphate buffer saline). Next, a 10 µl 
of MTT reagent (5 mg/ml in PBS) was added to each well including 
the blanks, which contained medium only. Cells were incubated with 
this yellow MTT solution for approximately 4 hr. After this 
incubation period, purple formazan salt crystals are formed. These 
salt crystals are insoluble in aqueous solution but were solubilized 
by incubating the plates with the solubilizing solution i.e. Dimethyl 
Sulfoxide (DMSO) (100 µl/well; maximum: 0.01 %) and overnight in 
a humidified atmosphere (37 °C, 5 % Carbon dioxide). The 
solubilized purple formazan product was spectrophotometrically 
quantified. The effect of plant extracts on cancer cells was quantified 
as the percentage of control absorbance of reduced dye at 550 nm 
on a microplate reader. Each experiment was repeated three times 
(n = 3). Mean and standard deviation were calculated between the 
three experiments. Results were calculated as percentage growth 
inhibition, untreated (control) cells versus treated cells according to 
the following formula:  
% Growth Inhibition=
Control-Actual absorbance
Control  X 100 
4 cells was 
placed in each well of a 96-well cell culture plate, making a total 
volume of 200 μl in each well. These dosed cells were incubated for 
72 hr in humidified 5 % CO2 atmosphere at 37 °C. The medium was 
removed by decantation and 200 μl fresh medium containing 50 
μg/ml Neutral red was added to each well. This was incubated for an 
additional 3 hr at 37 °C in 5 % CO2 atmosphere. This dye medium 
was then removed by decantation and each well was then washed 
rapidly with pre-warmed 200 μl PBS, followed by addition of 200 μl 
of acetic acid-water-ethanol in water (1:49:50). This mixture acts as 
a fixative agent, which allows the Neutral Red dye to fix with the 
cells. The cells were allowed to attach for 24 hr at 37 °C, 5% CO2 in 
air in a humidified atmosphere.  
The plates were kept at room temperature for 15 min so as to 
extract the dye and then the plates were covered in foil and placed 
on a plate shaker for 30 min to extract neutral red from the cells and 
form a homogeneous solution. The absorbance of the wells was 
measured at 540 nm spectrophotometrically within 60 min. Each 
experiment was repeated three times (n = 3) [22-24]. 
Actinomycin-D (4 µM), Tamoxifen (5 µM) and Anastrozole (5 µM) 
were used as positive controls. Anastrozole is a nonsteroidal 
inhibitor of aromatase which effectively blocks estrogen synthesis in 
postmenopausal women and is used as therapy of estrogen 
receptor-positive breast cancer [23]. So this was selected as 
standard for estrogen dependent cancer cell line. Tamoxifen may 
prevent estrogen-independent as well as estrogen-dependent breast 
cancer by stimulating phospholipase activity and initiating 
arachidonic acid release. The release of arachidonic acid and/or 
molecular reactions that accompany that release may initiate 
pathways that prevent tumor growth [24]. Actinomycin D, one of the 
oldest anticancer drugs, binds dsDNA (more strongly than dsRNA) 
and thus inhibits primarily cellular transcription. It is used in the 
treatment of a variety of tumors [27, 28]. 
Data presentation and statistical analysis 
All data were compiled from a minimum of three experiments (n=3). 
Data for statistical analysis were expressed as the mean±standard 
deviation. One-way ANOVA with Dunnett's multiple comparison test 
was performed using GraphPad Prism version 8 for Windows, to 
derive statistical significance of each test group to respective control 
group. Results with p<0.05 were considered as statistically significant. 
Identification and characterization of AMB 004 using melting 
point, FT-IR, Mass, NMR spectroscopy 
AMB 004 was subjected to determination of melting point. Then, it 
was chemically characterized using various spectroscopic 
techniques like FT-IR, ESI-MS, 1H NMR spectroscopy. The 
spectroscopic studies were performed at Sophisticated Analytical 
Instrumentation Facility, Panjab University, Chandigarh. 
Melting point 
Melting point was evaluated for the purified crystals and the values 
were checked with the literature value. 
FT-IR spectroscopy 
The FT-IR spectrum of the compound was recorded, using KBr 
pellets, in the range of wave number 4000-250 cm-1, with a 
resolution of 1 cm
The analysis was performed in hybrid quadrupole time of flight 
mass spectrometer equipped with electrospray ionization (ESI) and 
atmospheric pressure chemical ionization (APcl) sources having a 
mass range of 4000 amu and 20000 amu in ToF. The mass to charge 
-1. 
Mass spectroscopy 
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(m/z) ratio was recorded in the range of 50-1000 m/z. The collision 




H NMR spectra of the compound were recorded on the instrument 
FT NMR Spectrometer model Avance-II (Bruker) at 400 MHz 
frequency and 9.4 field strength. 
Bioactivity-guided fractionation 
The direct methanolic extract of A. monilifer was investigated for 
cytotoxic activity against four cancer cell lines. The results indicated 
the plant possessed very highly significant (p<0.001) concentration-
dependent growth inhibition (up to 95%) activity in the malignant 
cells, with the apparent IC50 value with the apparent IC50
The difference in the apparent IC
 values 
ranging between 100 µg/ml (NRU assay)-200 µg/ml (MTT assay) 
(table 1 and 2). 
50
S. No. 
 values can be justified by the 
physiological mechanisms on which these assays are based. As in the 
MTT assay, tetrazolium salts are reduced to formazan by 
mitochondrial succinate dehydrogenase, an enzyme which is active 
only in viable cells with an intact respiratory chain [29]. The uptake 
of neutral red depends on the lysosomal capacity to maintain pH 
gradients through the production of ATP [30]. 
 
Table 1: Cytotoxicity activity of AM-1 of A. monilifer using MTT assay after 24 hr of treatment 
Concentration (µg/ml) Percentage of growth inhibition of cancer cells±standard deviation 
MCF 7 MDA MB 231 HepG2 HLE 
1 10 18.23±1.33 14.66±2.12 19.34±2.42 23.29±3.29** 
2 25 29.12±2.04** 28.49±3.29** 26.34±3.21** 14.35±3.86 
3 50 51.77±4.31*** 50.85±3.12*** 43.14±2.85** 44.13±2.65** 
4 100 54.84±4.22*** 54.96±4.04*** 50.18±4.32*** 20.26±5.29** 
5 200 66.35±3.64*** 66.49±4.32*** 62.33±2.86*** 38.32±3.98** 
6 300 77.54±4.28*** 76.18±5.22*** 72.14±3.38*** 46.20±2.65** 
7 400 90.17±5.38*** 89.38±4.95*** 75.83±4.64*** 49.39±7.39** 
8 500 92.28±5.97*** 92.43±3.45*** 83.11±2.65*** 84.32±3.39*** 
9 Vehicle [0.01% DMSO in culture media] 2.02±3.68 2.07±4.38 1.03±3.64 2.01±3.28 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
Cytotoxicity experiment was also performed using NRU assay. NRU 
assay confirmed the results obtained in MTT assay. The results of 
NRU assay showed that extract inhibited the growth of MDA MB-231 
and HepG2 cells. It was found less effective in inhibiting the growth 
of MCF-7 and HLE cells, unlike MTT assay. IC50
S. No. 
 values for MCF-7 and 
HLE cells were found to be 200 µg/ml and 300 µg/ml, respectively 
for AM-1 from A. monilifer. The results of NRU assay performed for 
AM-1 is shown in table 2 
 
Table 2: Cytotoxic activity of AM-1 of A. monilifer using neutral red uptake assay after 24 h treatment 
Concentration µg/ml Percentage of growth inhibition of cancer cells±standard deviation 
MCF 7 MDA MB 231 HepG2 HLE 
 10 17.29±2.41 16.65±1.87 24.43±2.48 14.32±4.72 
2 25 37.43±3.86** 28.32±2.86** 30.29±2.12** 24.33±4.67* 
3 50 41.48±3.45** 49.22±3.76** 44.54±3.25** 38.32±2.98** 
4 100 37.76±2.88** 54.19±3.14** 51.55±3.87** 33.73±2.02* 
5 200 50.84±4.84*** 64.37±3.98*** 62.64±4.33*** 39.58±3.76** 
6 300 51.38±3.81*** 75.48±5.32** 72.93±3.54*** 47.52±6.48*** 
7 400 61.76±5.15*** 90.18±4.25*** 77.39±4.86*** 71.65±5.98*** 
8 500 84.54±6.39*** 93.37±4.87*** 83.32±4.12*** 88.47±7.43*** 
9 Vehicle [0.01% DMSO in culture media] 2.59±2.98 1.87±3.20 2.39±3.87 1.29±3.12 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
This preliminary screening revealed that AM-1 from A. monilifer 
contained chemical constituents capable of exerting cytotoxic 
activity against cells of selected cancerous cell lines. The apparent 
IC50
It was thought to isolate biologically active constituents from the 
plant, possessing cytotoxic activity, which might be responsible for 
cytotoxic activity of the plants. Bioactivity-guided fractionation 
approach was adopted for the selection of fractions to be taken up 
further for isolation of the constituents.  
 concentration was found to be 200 µg/ml, in both the assay 
methods. It was, thus, decided to screen the fractions obtained from 
both the extracts at a set concentration of 200µg/ml to ensure the 
cytotoxic potential of the respective fraction. 
The bioactive direct methanolic extract (AM-1) of the plant was 
partitioned into Hexane (AM-2), Chloroform (AM-3), Ethyl 
acetate (AM-4) and Methanolic (AM-5) fractions (fig. 1). 
Fractions AM-2, AM-3, AM-4 and AM-5 were evaluated for their 
cytotoxic activities at 200µg/ml in vitro, using MTT and NRU 
assays (table 1 and 2). 
 
Table 3: Cytotoxic activity of fractions (200 µg/ml) from A. monilifer using MTT assay after 24 h treatment 
S. 
No. 
FRACTION (200µg/ml) Percentage growth inhibition of cancer cells±Standard deviation 
MCF 7 MDA MB 231 HepG2 HLE 
1 Hexane (AM-2) 69.36±6.42** 11.61±2.44 17.41±1.54 8.27±3.29 
2 Ethyl acetate (AM-4) 76.93±4.86*** 71.14±5.12*** 69.74±3.82*** 24.43±5.12* 
3 Chloroform (AM-3) 93.88±5.64*** 94.02±5.88*** 89.89±4.82*** 87.12±3.52*** 
4 Methanol (AM-5) 65.37±4.34*** 42.13±1.54** 19.73±2.78* 21.87±2.17* 
5 Control 3.32±1.54 -1.31±2.18 3.28±1.12 2.66±4.22 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
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Cytotoxic activity of various fractions prepared from AM-1 was 
performed using NRU assay. The results showed that AM-3 inhibited 
the growth of MCF-7, MDA MB-231 and HepG2 cells by more than 
90%, while it was less effective in inhibiting the growth of HLE cells. 
AM-4 showed the almost parallel magnitude of cytotoxic activity on 
all cell lines. AM-1 showed less than 50% inhibition to cell growth at 
selected concentration levels. The results of the studies are shown in 
table 5.20. 
 
Table 4: Cytotoxic activity of fractions (200µg/ml) from A. monilifer using neutral red uptake assay after 24 h treatment 
S. No. Fraction (200µg/ml) MCF 7 MDA MB 231 HepG2 HLE 
1 Hexane (AM-2) 53.16±2.88** 21.39±3.80* 31.80±2.66* 11.58±4.29 
2 Ethyl acetate (AM-4) 81.67±4.86*** 77.92±3.26*** 81.16±5.28*** 37.29±2.84** 
3 Chloroform (AM-3) 93.81.±5.84*** 92.04±5.86*** 97.94±4.86*** 37.65±5.69** 
4 Methanol (AM-5) 46.04±2.28** 40.52±1.86** 38.25±3.62** 13.54±3.65 
5 Control -0.19±1.24 5.97±2.22 4.57±2.40 2.63±4.17 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
The cytotoxic activity was significantly observed in two fractions 
(AM-3 and AM-4, n=3 for each fraction, mean±sd) with similar 
results obtained with the NRU assay. AM-3 had the maximum 
effect. 
Fractionation of AM-3 of A. monilifer aerial parts (14g) in column 
chromatography with silica gel employed an isocratic elution 
system. The eluting solvent was ethyl acetate: hexane: acetone 
(7:3:5). This resulted in the isolation of a triterpenoidal compound 
AMB 004.  
Triterpenes are naturally occurring organic compounds, characterized 
by a high diversity of chemical structure and biological properties. They 
are becoming increasingly significant in the treatment of cancer due to 
their efficacy and safety. The anticancer triterpenoid saponins enable the 
inhibition of cancer formation and progression by various mechanisms 
like apoptosis, autophagy, etc. [31-33] 
Keeping all the above facts in mind, it was thought worthwhile to 
identify the triterpenoid in AM-3, which may be responsible for the 
cytotoxicity of the plant. 
Spectral characteristics of isolated compound (AMB 004) 
A 28 mg white powder of AMB 004 was isolated. For structure 
elucidation of this AMB 004, spectral analysis of the powder was 
done; the results of which are summarized in table 1. 
 
 
Fig. 3: Chemical structure of betulinic acid 
 
Table 5: Spectral characteristics of isolated triterpenoidal compound (AMB 004) 
S. No. Parameter Values References 





1.  0.22 [petroleum ether: ethyl acetate: toluene (7:2:1)] 
2.  0.62 [Ethyl acetate: Hexane (7:3)] 
19, 32 
3. Melting point 295-299 °C  
4. IR (KBr) 
 
Wave number (cm-1 Characteristic of:- ) 33, 34 
3442 Presence of hydroxyl function (-OH) 
2943 -CH3 and-CH2 asymmetric and symmetric vibrations 
1685 C-O stretching 
1451 O-H bending vibrations 
883 Vibration of–CH2 in alkene group 
5. 1H NMR (CDCl3 • 0.65, 0.77, 0.98, 1.14 and 1.34 (5s, 15H, all tertiary–CH3), ) 
• 1.37 (m, 2H, H-21), 
• 1.38 (m, 2H, H-16), 
• 1.45 (m, 2H, H-20), 
• 1.51 (m, 4H, H-18, H-19 and H-15), 
• 2.09 (m, 3H, H-1 and H-9), 
• 2.13 (m, 2H, H-14), 
• 3.17 (t, 2H, J =7 Hz, H-2), 
• 3.38 (s, 2H, H-7), 
• 4.56 (s, 2H, H-11), 





• M+= 457.51 
• Other fragments at m/z 438 [M-H2O], 411 [M-COOH], 248 [C16H24O2], 203 [248-COOH], 220 
[C15H24O], 203 [220-OH], 175 [220-COOH], 207 [C14H23O], 189 [207-H2O]  
33, 34 
The above I. R., 1
 
H-NMR and ESI-MS spectral data and their comparison with those described in literatures [19, 37, 38], revealed that probable 
structure of compound AMB 004 may be Betulinic acid (fig. 3). 
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Cytotoxic activity of isolated compound AMB 004 
From the above studies, it was found that betulinic acid is highly 
regarded for its cytotoxic properties due to its structural properties 
[39]. Also, the incidences of liver cancer and breast cancer are 
increasing over the time. In fact, these are the most common cancer 
types in some countries. Therefore the effectiveness of betulinic acid 
was investigated for the aforementioned cancer types.  
Preliminary screening of organic fractions against four cancer cell 
lines revealed the most potent cytotoxic fraction for the medicinal 
plant. Further assessment of these potent fractions highlighted that 
out of all the fractions, the fraction containing this compound 
(betulinic acid) has significant anticancer activity. 
Compound AMB 004 was evaluated for cytotoxic activity against 
four cancer cell lines (MCF-7, MDA MB 231, HepG2 and HLE). In this 
study, eight serial dilutions (0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, 100 
µM) of each compound containing DMSO (maximum: 0.01 %) were 
prepared in 200 µl media as a final concentration in the well. 
Cytotoxic activity of compound AMB 004 was evaluated at 24 hr and 
48 hr in order to establish a time as well as concentration-
dependent cytotoxic effect.  
Actinomycin-D (4 µM), Tamoxifen (5 µM) and Anastrozole (5 µM) 
were used as positive controls. For each cell line, a density of 1 
x104cells per well in 100 µl aliquots of medium was seeded into 96-
well cell culture plates. The cells were allowed to attach for 24 hr at 
3 °C, 5% CO2
Vehicle control groups received the same amount of DMSO 
(maximum: 0.01%). After a 24 hr and 48 hr drug exposure time, the 
toxic endpoints were determined. For each treatment, five replicate 
wells were examined, and each experiment was repeated three 
times (n = 3). Results were calculated as percentage growth 
inhibition, untreated (control) cells versus treated cells according to 
the formula as described previously (MTT assay). Mean and 
standard deviation was calculated between the three experiments. 
 in air in a humidified atmosphere. The next day, the 
serial dilutions of compound AMB 004 were added.  
The results from the MTT assay showed that statistically significant 
(P<0.01) inhibition (20-21%) of breast cancer cell MCF-7 started at a 
concentration of 6.24 µM, which became highly significant (p<0.001) 
at a concentration of 25 µM for MCF-7 cells after 24 hr treatment with 
Betulinic acid (table 6); while for MDA MB-231 cells, a highly 
significant inhibition (p<0.001) was observed at 50 µM (table 6). After 
a prolonged exposure to 48 h, the percentage inhibition was not much 
increased in MDA MB-231 (table 8). While in MCF 7 cells, % inhibition 
was increased to 85% at a concentration of 12.48 µM, then 
subsequently showing a very highly significant inhibition of 98% at a 
concentration of 100 µM. Therefore, a selective growth inhibition of 
cancer cells by Betulinic acid was observed for the oestrogen 
dependent cancer cell line (MCF-7), while this triterpene could not 
retard the growth effectively in the estrogen independent cancer cells 
(MDA MB-231), where highly significant inhibition of 67% was 
observed at a concentration of 50 µM after 48 h. (table 8) 
 
Table 6: Cytotoxic activity of betulinic acid from A. monilifer against four cancer cell lines using MTT assay after 24 h treatment 
S. No. Betulinic acid (µM) MCF 7 MDA MB 231 HepG2 HLE 
1 0.78 4.57±3.18 4.18±3.87 12.67±3.12 4.29±3.28 
2 1.56 9.80±4.32 5.78±5.98 12.76±2.93 5.29±2.82 
3 3.12 7.59±2.45 13.20±2.78 20.43±6.45* 13.89±2.27 
4 6.24 21.46±4.33* 12.44±2,87 23.45±4.23* 12.87±3.76 
5 12.48 34.38±2.97** 20.42±5.40* 50.64±6.33*** 20.11±4.12* 
6 25.0 96.56±7.19*** 25.55±3.84* 78.88±8.92*** 24.98±5.54* 
7 50.00 98.12±5.48*** 52.41±2.93*** 80.10±8.92*** 53.21±6.76*** 
8 100.00 98.32±6.43*** 61.90±7.38*** 88.34±6.34*** 60.27±4.34*** 
9 Actinomycin D 5µM 83.88±8.92*** 65.76±8.59*** 57.78±7.12*** 66.16±6.18*** 
10 Tamoxifen 5µM 83.98±9.89*** 27.65±10.23* --- -- 
11 Anastrozole 5µM 50.72±6.78*** 70.21±12.40*** --- -- 
12 Vehicle control 0.54±3.85 4.25±3.44 1.48± 2.07±2.43 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
Table 7: Cytotoxic activity of betulinic acid from A. monilifer against four cancer cell lines using neutral red uptake assay after 24 h 
treatment 
S. No. Betulinic acid (µM) MCF 7 MDA MB 231 HepG2 HLE 
1 0.78 3.76±4.39 4.86±1.29 14.78±4.23 4.26±2.13 
2 1.56 5.66±1.87 6.14±2.39 23.74±8.65** 6.58±3.18 
3 3.12 8.69±4.23 9.87±4.22 40.42±3.77** 9.12±3.22 
4 6.24 21.92±3.12* 13.79±3.12* 56.59±4.58** 20.95±4.52** 
5 12.48 43.54±4.23** 16.98±3.67*** 71.69±8.92*** 16.28±1.87 
6 25.0 68.81±2.18*** 27.99±4.29*** 81.25±3.95*** 28.18±5.12* 
7 50.00 70.24±3.77*** 52.19±2.76*** 84.14±5.94*** 51.64±4.87** 
8 100.00 85.63±8.92*** 68.82±6.33*** 99.75±6.46*** 66.65±2.64*** 
9 Actinomycin D, 5µM 90.88±7.43*** 89.14±3.12*** 65.12±4.23** 87.28±6.19*** 
10 Tamoxifen 5µM 78.43±5.96*** 38.48±8.73*** -- -- 
11 Anastrozole 5µM 46.42±4.23** 74.32±9.23*** -- -- 
12 Vehicle control -2.68±2.33 0.11±4.30 1.32±2.93 2.11±2.11 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
The inhibition can be further justified with the NRU assay. The 
results showed that significant inhibition started early at 6.24 µM for 
MCF-7 cells after 24 hr exposure and exhibited a very highly 
significant effect (68%) at as little as 25 µM (table 7), which 
increased very significantly after 48 h i.e. 97% at 100 µM (table 9). 
In case of estrogen independent breast cancer cells (MDA MB-231), 
the highly significant effect of 52% was observed at 50µM after 24 
hr (table 7), but this inhibition increased slightly to 65% inhibition 
calculated after 48 h (table 9). 
Results showed that a significant inhibition (21%) was achieved at 
6.24 µM in HLE cells; similarly HepG2 cells achieved a significant 
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inhibition (23%) was achieved at 1.56 µM itself (table 7). All the 
above results are with respect to untreated cells (control). The 
cytotoxic effect on HepG2 was observed at a very low concentration 
(1.56 µM) with neutral red uptake assay after 48 hr treatment (table 
9), while that can be seen to be increased to a highly significant 
activity of 65% at 50µM in HLE cells (table 9). 
 
Table 8: Cytotoxic activity of Betulinic acid from A. monilifer against four cancer cell lines using MTT assay after 48 h treatment 
S. No. Betulinic acid (µM) MCF 7 MDA MB 231 HepG2 HLE 
1 0.78 4.87±2.14 5.72±2.18 6,86±1.19 5.28±2.32 
2 1.56 5.12±3.01 13.64±2.72 13.87±2.49 12.98±2.65 
3 3.12 6.88±3.13 16.75±3.27 45.76±3.83*** 15.98±3.82 
4 6.24 37.81±4.28** 12.76±2.39 60.21±4.72*** 11.96±3.17 
5 12.48 85.54±5.38*** 17.97±2.41 88.12±5.33*** 16.54±3.73 
6 25.0 98.53±6.43*** 29.88±2.83** 95.21±5.98*** 28.92±4.12* 
7 50.00 97.65±6,39*** 67.12±4.49*** 95.93±6.12*** 66.59±4.56*** 
8 100.00 98.13±5.89*** 77.97±4.25*** 98.54±5.29*** 75.19±4.71*** 
9 Actinomycin D 4µM 78.45±4.19*** 87.32±5.39*** 90.49±4.83*** 87.26±5.05*** 
10 Tamoxifen 5µM 98.54±3.63*** 87.42±6.58*** -- 86.79±4.97*** 
11 Anastrozole 5µM 47.34±2.87** 44.86±3.29** -- 46.96±2.28** 
12 Vehicle control 4.71±2.21 2.65±2.11 1.6±1.21 2.07±3.11 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
Table 9: Cytotoxic activity of Betulinic acid from A. monilifer against four cancer cell lines using Neutral Red Uptake assay after 48 h 
treatment 
S. No. Betulinic acid (µM) MCF 7 MDA MB 231 HepG2 HLE 
1 0.78 12.14±2.52 6.48±3.52 8.50±2.19 6.32±3.11 
2 1.56 14.23±2.93 11.25±2.83 20.87±2.76* 10.97±2.27 
3 3.12 27.97±3.84* 14.34±2.09 54.78±2.79** 13.98±3.92* 
4 6.24 54.98±4.12*** 24.97±2.95* 63.94±3.11*** 25.01±2.87** 
5 12.48 98.56±5.81*** 28.18±3.27* 96.94±5.39*** 27.76±3.22** 
6 25.0 99.13±5.39*** 35.55±4.73** 97.45±6.75*** 34.85±3.17** 
7 50.00 97.18±5.72*** 65.94±4.38*** 98.12±5.73*** 65.16±4.29*** 
8 100.00 97.43±6.82*** 79.38±5.17*** 99.51±7.12*** 78.28±6.82*** 
9 Actinomycin D 4µM 98.93±5.44*** 88.21±6.19*** 96.67±6.49*** 87.48±7.21*** 
10 Tamoxifen 5µM 99.63±5.29*** 62.98±4.49*** -- -- 
11 Anastrozole 5µM 35.89±3.29** 91.59±5.26*** -- -- 
12 Vehicle control 1.52±1.55 4.31±3.28 3.17±1.35 2.54±3.28 
Where statistically (Dunnett's multiple comparison test)* = Significant (P<0.05), ** = Highly significant (P<0.01), *** = Very highly significant 
(P<0.001), (n=3); Data expressed as mean±standard deviation 
 
DISCUSSION 
Medicinal Plants have a long history of use in the treatment of 
cancer. Plants have formed the basis for traditional medicine 
systems, which have been used for thousands of years in countries 
such as China [41], India and Pakistan [42, 43]. Hartwell, in his 
review of plants used against cancer, lists more than 3000 plant 
species that have reportedly been used in the treatment of cancer 
[44]. An impressive number of anticancer drugs have been isolated 
or derived from medicinal plants, are currently in clinical practice, 
based on their folklore use [45]. 
Cancer chemotherapy plays a significant role in the treatment of 
many malignancies, either curative or palliative care, depending 
upon the specific tumour condition [46]. The main objective of any 
cancer chemotherapy is to kill cancer cells with as little damage as 
possible to normal cells [47]. 
These results indicate all the two plants possess very highly 
significant (P<0.001) concentration-dependent growth inhibition 
(up to 95%) activity in the malignant cells (as shown in Tables 1 and 
2), with the apparent IC50 values ranging between 100 µg/ml (MTT 
assay)-200 µg/ml (NRU assay). 
The difference in the apparent IC50
The uptake of neutral red depends on the lysosomal capacity to 
maintain pH gradients through the production of ATP [30]. The 
weakly cationic dye penetrates cell membranes by non-ionic passive 
diffusion enabling a proton gradient to maintain a pH lower than 
that of cytoplasm. Thus, the dye becomes charged and retained 
inside the Iysosomes of metabolically active cells, characterizing the 
neutral red uptake assay as a more sensitive technique, 
differentiating between the dead and metabolically active cells that 
have a tendency to proliferate in the cultured cell population [48]. 
A serial dilution of eight concentrations (0.78, 1.56, 3.12, 6.25, 12.5, 25, 
50, 100 µM) for isolated compound AMB 004 was tested using two cell 
viability assays (MTT and Neutral Red Uptake assays) for 24 hr and 48 
hr treatments. Three positive controls were used: Actinomycin-D (4 µM, 
inhibitor of protein synthesis), Tamoxifen (5 µM, oestrogen receptor 
antagonist) and Anastrozole (5 µM, aromatase inhibitor).  
AMB 004 was isolated from the chloroform fraction of the 
methanolic extract of A. monilifer. AMB 004 showed a highly 
significant selective growth inhibition against oestrogen dependent 
breast cancer cells (MCF-7) and HepG2, while in MDA MB-231cells, 
moderate cytotoxic activity was observed. The results of MTT and 
neutral red uptake assays for percentage inhibition of cell growth 
over a concentration range for the four cancer cell lines, after 24 hr 
and 48 h are summarized in Tables 6 to 9. Cytotoxicity studies of 
Betulinic acid from A. monilifer against HLE and HepG2 cells 
indicated that this triterpene possessed more cytotoxic activity for 
hepatic carcinoma cells (HepG2 and HLE cells) as compared to 
breast cancer cells (MCF-7 and MDA MB-231) and that too more 
specifically for HepG2 cells. 
 values can be justified by the 
physiological mechanisms on which these assays are based. As in the 
MTT assay, tetrazolium salts are reduced to formazan by 
mitochondrial succinate dehydrogenase, an enzyme which is active 
only in viable cells with an intact respiratory chain [29]. 
The various results of MTT assay suggest that betulinic acid 
(isolated from A. monilifer) might be damaging the respiratory chain 
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in mitochondria of cells by apoptosis, which leads to decreased 
formation of NADPH [49]. NADPH is responsible for the expression 
of oxidoreductase enzymes i.e. succinate dehydrogenase in 
Mitochondria. This oxidoreductase enzyme reduces yellow coloured 
MTT dye to blue colored crystals of Formazan. The amount of 
Formazan formed is the measure of mitochondria of viable cells. 
This resultant blue coloured Formazan was measured from the 
absorbance in the visible range. [40] 
The triterpene (Betulinic acid) isolated in this study is novel for this 
plant. The triterpene is reported for the first time in the genus and 
the plant, as well. Also, no activity on tumour cells has been reported 
yet for the plant.  
CONCLUSION 
The results from the present study are in agreement with the 
ethnobotanical or traditional use of A. monilifer against cancer 
growth. The current research work has established that the 
cytotoxic activity of the plant against MCF-7, MDA-MB-231, HLE and 
HepG2 cells was highly significant with 90% growth inhibition. A 
triterpene, Betulinic acid, was isolated from the aerial parts of A. 
monilifer. The cytotoxic activity of the plant can be attributed to 
Betulinic acid. It is the first report of isolation of betulinic acid from 
the Alysicarpus species.  
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